CLIMARA 50 PATCH

Страна: Канада

мова: англійська

Джерело: Health Canada

Активний інгредієнт:

ESTRADIOL (ESTRADIOL HEMIHYDRATE)

Доступна з:

BAYER INC

Код атс:

G03CA03

ІПН (Міжнародна Ім'я):

ESTRADIOL

Дозування:

50MCG

Фармацевтична форма:

PATCH

Склад:

ESTRADIOL (ESTRADIOL HEMIHYDRATE) 50MCG

Адміністрація маршрут:

TRANSDERMAL

Одиниць в упаковці:

4

Тип рецепту:

Prescription

Терапевтична области:

ESTROGENS

Огляд продуктів:

Active ingredient group (AIG) number: 0106457035; AHFS:

Статус Авторизація:

APPROVED

Дата Авторизація:

2007-03-08

Характеристики продукта

17β)
·
·
·
·
·
·
·
·
·
·
·
·
·
·
=
·
·
·
·
·
·
·
·
·
·
·
·
–
≥
–
≥
–
≥
*
John’s wort.
·
·
·
·
·
17β. Upon application to
17β, the major estrogenic hormone secreted by the human ovary.
17β is the predominant estrogen produced by the ovaries in
premenopausal women.
17β), and provides controlled delivery of estradiol
17β,
17β), and provides controlled delivery of estradiol
17β, 0.05
17β), and provides controlled delivery of estradiol
17β,
17β)
PART II: SCIENTIFIC INFORMATION
β
2 •
–
–
–
–
–
–
–
–
–
–
–
–
17β per day) is not approved for
completed the study. Both CLIMARA 50 and CLIMARA 100 were
significantly (p ≤ 0.05) more
efficacy parameters. Statistically significant (p ≤ 0.05) treatment
effects with both doses were
–
change from baseline significantly (p≤0.05) less for placebo group
than for the CLIMARA 50 and CLIMARA 100
Mean score significantly (p≤0.05) less for the placebo group than
for the CLIMARA 50 and CLIMARA 100
CLIMARA 50 and CLIMARA 100 statistically significant at p ≤ 0.05.
–
Mean score significantly (p ≤ 0.05) less for the for the CLIMARA 50
group than for the CLIMARA 100
Mean score significantly (p ≤ 0.05) less for the for the CLIMARA 50
group than for the CLIMARA 100 group, and, mean score
significantly (p ≤ 10.05) less for the
–
–
–
–
–
–
Patient’s Assessment
Investigator’s Assessment
Patient’s Assessment
Investigator’s Assessment
–
–
–
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
†
<0.0001‡
<0.0001 ‡
0.0001 ‡
<0.0001‡
<0.0001 ‡
†
‡ p < 0.05
17β per day) is not approved for sale in Canada.
–
†
†
†
†
†
†
†
†
†
†
–
†
†
†
†
†
†
†
†
†
†
0.0141 ‡
<0.0001 ‡
0.0001 ‡
<0.0001 ‡
<0.0001 ‡
†
‡ p < 0.05
17β per day) is not approved for sale in Canada.
–
crease in bone mineral density at the hip (trochanteric region,
Ward’s triangle, femoral neck) and spine
Ward’s Triang